City
Epaper

2 arthritis drugs show different results in Covid-19 trials

By IANS | Updated: April 28, 2020 22:25 IST

With different approaches to treating Covid-19 patients being tried, varying results of two different arthritis drug trials on patients have further complicated the search for a cure.

Open in App
inhibitor tocilizumab rapidly reduced fever and improved oxygenation in severe patients, allowing for successful hospital discharge.

gb/arm

( With inputs from IANS )

Open in App

Related Stories

National14.5 kg of IED recovered & neutralised in J&K's Shopian, averts major terror incident

InternationalWhite House pushed Pakistan to broker US-Iran temporary ceasefire: Report

NationalOver 23 lakh pilgrims paid obeisance at J&K's Shri Mata Vaishno Devi Shrine in 2026

Politics"Mamata Banerjee's ruthless govt created anarchy....": BJP chief Nitin Nabin

Cricket"Very pleased to get over the line": GT captain Shubman Gill after thrilling 1-run win over DC

Health Realted Stories

HealthJharkhand HC seeks detailed probe report on HIV-infected blood transfusion in Chaibasa

HealthTejashwi Yadav targets Health Minister Mangal Pandey over viral Gaya hospital video

Health‘Poshan Pakhwada 2026’ to focus on maximising brain development in 1st 6 years of life

HealthTurmeric Milk Benefits: Know When to Drink It for Best Results

HealthWhat Is Second-Hand Stress? How Others’ Anxiety Can Affect Your Mental Health